Triangle Phase III Coviracil data

VIRS said that in a Phase III study (FTC-302) comparing its once daily Coviracil emtricitabine (FTC) nucleoside analog to twice daily Epivir lamivudine 3TC in 468 HIV patients, 61 percent of Coviracil...